Matching slides 110,355
Current window 78,421-78,450
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

78,421-78,450 of 110,355

filter-aware
24
The slide uses a highlighted excerpt from a third-party report to undermine the company's R&D track record.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
25
The slide uses a screenshot of a press release to validate the claim of continued product success.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
26
The slide uses analyst quotes to build a case for competitive pressure on Pfizer's core product.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
27
The slide uses a direct quote from a press release to highlight a clinical trial failure.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
28
The slide uses a primary source excerpt to establish the clinical efficacy and subsequent commercial success of the drug.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
29
The slide uses a screenshot of a news article as evidence.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
32
Uses highlighted text to draw attention to specific claims within the quotes.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
33
The slide highlights the skepticism of Wall Street analysts regarding management's projections.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
34
Uses a 'villain critique' style to undermine management's R&D track record.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
35
The chart highlights the massive gap between company optimism and market reality.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
36
The chart highlights the divergence in GLP-1 success between the two peers and the implied laggard (Pfizer).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
39
The chart uses a 'broken axis' visual style for the top two bars (LLY, NVO) to accommodate their significantly higher growth rates.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
40
The chart uses a broken axis for the top two performers (NVO, LLY) to accommodate the scale.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
42
The slide highlights the scale of capital allocation into M&A, framing it as a potential misuse of COVID-19 windfall cash.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
43
The slide uses a visual comparison to contrast the $70B spend against the $20.5B revenue target, implying poor capital allocation.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
44
The chart uses a red bar to emphasize the outlier status of the 'PFE Consolidated Deals (Mgmt)' metric.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
45
The slide uses a stacked bar chart to contrast company expectations ($20.5bn) against sell-side consensus ($13.3bn).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
46
The chart highlights the discrepancy between management's valuation assumptions and consensus expectations.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
47
The slide uses a combination of a table and a bar chart to illustrate the delta in valuation.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
48
Uses a press release excerpt with annotations to build a valuation argument.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
49
The slide uses a direct quote/screenshot from a press release to undermine the value of a previous acquisition (GBT).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
50
The slide uses analyst quotes to frame Pfizer's acquisition strategy as flawed.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
52
Uses checkmarks and X marks to visualize performance; highlights 2021-2022 as a 'COVID Benefit' period.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
53
The chart uses color coding (red bars) to emphasize Pfizer's lower consistency compared to the peer group.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
54
Uses red 'X' icons to visually emphasize the failure to meet expectations.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
55
The slide uses a waterfall-like annotation to explain the drop in sales from 2022 to 2023.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
56
The slide uses a chart to highlight management's optimistic outlook, likely to contrast with actual performance or market skepticism.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
57
The slide uses a red color for the actuals bar and the annotation to emphasize the negative performance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
58
Uses red color coding to emphasize the negative performance and missed guidance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
59
Uses a red-blue contrast to emphasize the negative gap between market expectations and company guidance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit